blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2073789

EP2073789 - A STABLE COMPOSITION COMPRISING A BONE ANABOLIC PROTEIN, NAMELY A PTHRP ANALOGUE, AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.03.2020
Database last updated on 04.06.2024
FormerThe patent has been granted
Status updated on  19.04.2019
FormerGrant of patent is intended
Status updated on  30.01.2019
FormerExamination is in progress
Status updated on  11.12.2018
FormerGrant of patent is intended
Status updated on  31.07.2018
FormerExamination is in progress
Status updated on  08.06.2018
FormerGrant of patent is intended
Status updated on  06.02.2018
FormerExamination is in progress
Status updated on  09.01.2017
Most recent event   Tooltip06.01.2023Correction of patent specificationpublished on 08.02.2023  [2023/06]
Applicant(s)For all designated states
Radius Health, Inc.
950 Winter Street
Waltham, MA 02451 / US
For all designated states
IPSEN PHARMA S.A.S.
65, Quai Georges Gorse
92100 Boulogne-Billancourt / FR
[2016/33]
Former [2009/37]For all designated states
Radius Health, Inc.
300 Technology Square, 5th Floor
Cambridge, MA 02139-3520 / US
For all designated states
IPSEN PHARMA S.A.S.
65, Quai Georges Gorse
92100 Boulogne-Billancourt / FR
Former [2009/27]For all designated states
Radius Health, Inc.
300 Technology Square, 5th Floor
Cambridge, MA 02139-3520 / US
For all designated states
IPSEN PHARMA S.A.S.
65, quai Georges Gorse
91200 Boulogne-Billancourt / FR
Inventor(s)01 / DEY, Michael J.
40 Park Lane
Sandbach
Cheshire CW11 1EW / GB
02 / MONDOLY, Nathalie
Résidence Ranelagh
5, Square Raphael
78150 Le Chesnay / FR
03 / RIGAUD, Benedicte
2, Chemin De Rouvres
28260 Oulins / FR
04 / HENDERSON, Bart
48 Prentiss Lane
Belmont, MA 02478 / US
05 / LYTTLE, C. Richard
120 Edgehill Road
Bala Cynwyd, PA 19004 / US
06 / DONG, Zhengxin
Holliston, MA 01746 / US
 [2023/04]
Former [2022/38]01 / DEY, Michael J.
40 Park Lane
Sandbach
Cheshire CW11 1EW / GB
02 / MONDOLY, Nathalie
Résidence Ranelagh
5, Square Raphael
78150 Le Chesnay / FR
03 / RIGAUD, Benedicte
2, Chemin De Rouvres
28260 Oulins / FR
04 / HENDERSON, Bart
48 Prentiss Lane
Belmont, MA 02478 / US
05 / LYTTLE, C. Richard
120 Edgehill Road
Bala Cynwyd, PA 19004 / US
06 / ZHENGXIN, Dong
Holliston, MA 01746 / US
Former [2019/21]01 / DEY, Michael J.
40 Park Lane
Sandbach
Cheshire CW11 1EW / GB
02 / MONDOLY, Nathalie
Résidence Ranelagh
5, Square Raphael
78150 Le Chesnay / FR
03 / RIGAUD, Benedicte
2, Chemin De Rouvres
28260 Oulins / FR
04 / HENDERSON, Bart
48 Prentiss Lane
Belmont, MA 02478 / US
05 / LYTTLE, C. Richard
120 Edgehill Road
Bala Cynwyd, PA 19004 / US
Former [2009/27]01 / DEY, Michael J.
40 Park Lane Sandbach
Cheshire CW11 1EW / GB
02 / MONDOLY, Nathalie
Residence Ranelagh 5, Square Raphael
78150 Le Chesnay / FR
03 / RIGAUD, Benedicte
2, Chemin De Rouvres
28260 Oulins / FR
04 / HENDERSON, Bart
48 Prentiss Lane
Belmont, MA 02478 / US
05 / LYTTLE, C. Richard
120 Edgehill Road
Bala Cynwyd, PA 19004 / US
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2019/21]Potter Clarkson
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Former [2013/37]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham
NG1 5GG / GB
Former [2013/34]Stevens, Ian Edward, et al
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Former [2009/27]Snodin, Michael D.
Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham
NG1 5DD / GB
Application number, filing date07870768.403.10.2007
[2009/27]
WO2007US21216
Priority number, dateUS20060848960P03.10.2006         Original published format: US 848960 P
[2009/27]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008063279
Date:29.05.2008
Language:EN
[2008/22]
Type: A2 Application without search report 
No.:EP2073789
Date:01.07.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 29.05.2008 takes the place of the publication of the European patent application.
[2009/27]
Type: B1 Patent specification 
No.:EP2073789
Date:22.05.2019
Language:EN
[2019/21]
Type: B8 Corrected title page of specification 
No.:EP2073789
Date:14.09.2022
[2022/37]
Type: B8 Corrected title page of specification 
No.:EP2073789
Date:08.02.2023
[2023/06]
Search report(s)International search report - published on:EP25.06.2009
ClassificationIPC:A61K9/00, A61K9/08, A61K38/29, A61P19/10
[2018/09]
CPC:
A61K9/08 (EP,NO,US); A61K38/29 (EP,NO,US); A61K47/14 (KR);
A61K38/16 (KR); A61K47/02 (KR); A61K9/00 (NO);
A61K9/0019 (EP,US); A61P19/00 (EP); A61P19/08 (EP);
A61P19/10 (EP,NO); A61P31/04 (EP) (-)
Former IPC [2009/27]A61K9/00, A61K9/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2019/21]
Former [2009/27]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL30.03.2009
BA30.03.2009
HR30.03.2009
MK30.03.2009
RS30.03.2009
TitleGerman:STABILE ZUSAMMENSETZUNG MIT ANABOLISCHEM KNOCHENPROTEIN, UND ZWAR EINEM PTHRP-ANALOGON, SOWIE DEREN VERWENDUNG[2018/09]
English:A STABLE COMPOSITION COMPRISING A BONE ANABOLIC PROTEIN, NAMELY A PTHRP ANALOGUE, AND USES THEREOF[2009/27]
French:COMPOSITION STABLE D'UNE PROTÉINE ANABOLIQUE OSSEUSE QUI EST UN ANALOGUE DE PTHRP, ET SES EMPLOIS[2018/09]
Former [2009/27]STABILE ZUSAMMENSETZUNG MIT ANABOLISCHEM KNOCHENPROTEIN, UND ZWAR EINEM PTHRP-ANALOGON, SOWIE VERWENDUNG
Former [2009/27]PROCÉDÉ D'ADMINISTRATION PHARMACOLOGIQUE D'UNE PROTÉINE ANABOLIQUE OSSEUSE
Entry into regional phase30.03.2009National basic fee paid 
30.03.2009Designation fee(s) paid 
30.03.2009Examination fee paid 
Examination procedure30.03.2009Examination requested  [2009/27]
03.04.2009Amendment by applicant (claims and/or description)
27.06.2016Despatch of a communication from the examining division (Time limit: M06)
06.01.2017Reply to a communication from the examining division
07.02.2018Communication of intention to grant the patent
06.06.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
01.08.2018Communication of intention to grant the patent
10.12.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
31.01.2019Communication of intention to grant the patent
11.04.2019Fee for grant paid
11.04.2019Fee for publishing/printing paid
11.04.2019Receipt of the translation of the claim(s)
23.12.2022Request for correction of the decision to grant filed
Divisional application(s)EP15176548.4  / EP2957278
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.06.2016
Opposition(s)24.02.2020No opposition filed within time limit [2022/37]
25.02.2020No opposition filed within time limit [2020/18]
25.02.2020No opposition filed within time limit [2022/38]
25.02.2020No opposition filed within time limit [2023/04]
Fees paidRenewal fee
26.10.2009Renewal fee patent year 03
25.10.2010Renewal fee patent year 04
25.10.2011Renewal fee patent year 05
25.10.2012Renewal fee patent year 06
28.10.2013Renewal fee patent year 07
14.10.2014Renewal fee patent year 08
12.10.2015Renewal fee patent year 09
11.10.2016Renewal fee patent year 10
11.10.2017Renewal fee patent year 11
11.10.2018Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.10.2007
CY22.05.2019
CZ22.05.2019
EE22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
MT22.05.2019
PL22.05.2019
RO22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
BG22.08.2019
GR23.08.2019
IS22.09.2019
[2021/34]
Former [2021/33]HU03.10.2007
CY22.05.2019
CZ22.05.2019
EE22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
PL22.05.2019
RO22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
BG22.08.2019
GR23.08.2019
IS22.09.2019
Former [2021/31]CY22.05.2019
CZ22.05.2019
EE22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
PL22.05.2019
RO22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
BG22.08.2019
GR23.08.2019
IS22.09.2019
Former [2021/26]CY22.05.2019
CZ22.05.2019
EE22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
PL22.05.2019
RO22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
BG22.08.2019
GR23.08.2019
Former [2020/25]CZ22.05.2019
EE22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
PL22.05.2019
RO22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
BG22.08.2019
GR23.08.2019
Former [2020/17]CZ22.05.2019
EE22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
RO22.05.2019
SK22.05.2019
TR22.05.2019
BG22.08.2019
GR23.08.2019
Former [2020/11]CZ22.05.2019
EE22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
RO22.05.2019
SK22.05.2019
BG22.08.2019
GR23.08.2019
Former [2020/10]CZ22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
RO22.05.2019
BG22.08.2019
GR23.08.2019
Former [2020/09]CZ22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
BG22.08.2019
GR23.08.2019
Former [2019/51]FI22.05.2019
LT22.05.2019
LV22.05.2019
BG22.08.2019
GR23.08.2019
Former [2019/47]FI22.05.2019
LT22.05.2019
Cited inInternational search[X]WO03105772  (BETH ISRAEL HOSPITAL [US], et al) [X] 1-49 * claims 1-67 * * page 16, line 4 - page 17, line 4 * * page 10, line 11 ** table 3 *;
 [X]US2005282749  (HENRIKSEN DENNIS B [DK], et al) [X] 1-19,21,24-49 * paragraphs [0493] , [0502] - [0504] - [0521] , [0527] * * page 21, column R, line 20 - page 21, column R, line 21 * * claims 1-24 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.